Literature DB >> 12224535

Commentary on: "Stereotyped activities produced by amphetamine in several animal species and man." Psychopharmacologia (1967) 11:300-310. A landmark publication from the early days of the dopamine hypothesis.

R Fog1, A Randrup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224535     DOI: 10.1007/s00213-002-1089-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  6 in total

1.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

Review 2.  On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.

Authors:  R Fog
Journal:  Acta Neurol Scand Suppl       Date:  1972

3.  Stereotyped activities produced by amphetamine in several animal species and man.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1967

4.  Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues.

Authors:  H Nybäck; G Sedvall
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

5.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

6.  Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1965-05-21
  6 in total
  1 in total

1.  The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.

Authors:  S M Aarde; P K Huang; K M Creehan; T J Dickerson; M A Taffe
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.